Abstract:
A wirelessly detectable tamper-evident seal (1) including a receptacle part (10) and a frangible part (50), the receptacle part (10) including a first receptacle (10a) and a second receptacle (10b-d) attachable to a container to seal a closure of the container and the frangible part (50) including a first portion (51) and a second portion (52) frangibly connected to each other, the first receptacle (10a) adapted to receive the first portion (51) and the second receptacle (10b-d) adapted to receive the second portion (52), the frangible part (50) including a transponder (54), the second portion (52) able to be trapped against movement in the reverse direction in the second receptacle (10b-d) to effect a tamper evident seal between the first and second receptacles (10a-d), wherein the transponder (54) includes at least two circuit interruption locations (94a, 94b) that must be connected to activate the transponder (54) and the transponder (54) is activatable by inserting the second portion (51) in the second receptacle (10b-d) whereby to connect both or all circuit interruption (94a,94b) locations.
Abstract:
Packaging and a dessert food product combines a hot portion and a cold portion. In one embodiment, the dessert combines hot pie with a topping of ice cream in a single package. In one aspect of the invention, the microwaveable food product and package incorporates a food package that simultaneously includes various susceptor films that allow for differential heating of food. The susceptor film(s) shield the cold-portion food products from being heated in the microwave while they provide even heating of the hot portion of the product. The packaging provides a quick, convenient and tasty dessert with minimal effort. In another aspect of the present invention, the pie and ice cream formulation has been optimized to maintain superior flavor and texture properties after freezing and microwave reheating.
Abstract:
The present invention relates to pyridyl substituted heterocycles and hydro isomers thereof and pharmaceutical compositions thereof that inhibit replication and/or proliferation of HCV virus. The present invention also relates to the use of the pyridyl heterocycles and hydro isomers thereof and/or pharmaceutical compositions comprising the compounds to treat or prevent HCV infections.
Abstract:
A process for preparing (+)-(2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol, pharmaceutically acceptable salts and solvates thereof such as the (+)-(2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethyl-2-morpholinol hydrochloride salt via enzyme-catalyzed dynamic kinetic resolutions is provided.
Abstract:
This invention relates to compounds of formula (I): wherein R1 is a branched or straight chain C1-C6 alkyl; R2 is of the formula (II), wherein n is an integer ranging from 1 to 8; R5 is H or (CH2)pCH3, and R6 is H or (CH2)mOH, wherein p is an integer ranging from 1 to 7 and m is an integer ranging from 1 to 8; R3 is of the formula (III), wherein q is an integer ranging from 1 to 8; and R7 is selected from the group consisting of H, OH, NH2, (CH2)tOH, and R9COOH; wherein R9 is a straight or branched chain alkylene or alkenylene group having 1 to 8 carbon atoms, and t is an integer ranging from 1 to 8; R4 is of the formula (IV), wherein r is an integer ranging from 1 to 8 and R8 is selected from the group consisting of H, OH, (CH2)fNH2, (CH2)sOH, and R10COOH; wherein f is 0 or f and s are independently integers ranging from 1 to 8; and, R10 is a C1-C8 straight or branched chain alkylene or alkenylene; and; salts, solvates, and hydrates thereof. The present invention further provides methods of preparing the compounds of formula (I) and their use as therapeutic agents and diagnostic agents.
Abstract:
Methods and compositions for treating and preventing respiratory disorders are provided. The methods of the invention comprise administering to a subject a therapeutically effective amount of a pharmaceutically acceptable salt of an A1 adenosine receptor antagonist, particularly 1-hydroxy-2-naphthoic acid salts or 3-hydroxy-2-naphthoic acid salts, more particularly a 1-hydroxy-2-naphthoic acid salt of 3-[2-(4-aminophenyl)ethyl]-8-benzyl-7-{2-[ethyl-(2-hydroxyethyl)amino]ethyl}-1-propyl-3,7-dihydropurine-2,6-dione (i.e., an L-97-1 xinafoic acid salt). Hydrates of the A1 adenosine receptor antagonist salts described herein are further provided. The invention further encompasses pharmaceutical compositions comprising a pharmaceutically acceptable salt of an A1 adenosine receptor antagonist in a pharmaceutically acceptable carrier. The compositions of the invention find use in methods for treating and preventing respiratory disorders.
Abstract translation:提供了治疗和预防呼吸系统疾病的方法和组合物。 本发明的方法包括向受试者施用治疗有效量的A 1 N 2腺苷受体拮抗剂的药学上可接受的盐,特别是1-羟基-2-萘甲酸盐或3-羟基-2 - 萘甲酸盐,更特别是3- [2-(4-氨基苯基)乙基] -8-苄基-7- {2- [乙基 - (2-羟乙基)氨基]乙酸的1-羟基-2-萘甲酸盐, 乙基} -1-丙基-3,7-二氢嘌呤-2,6-二酮(即L-97-1十一酸盐)。 进一步提供本文所述的A 1 N 2腺苷受体拮抗剂盐的水合物。 本发明还包括在药学上可接受的载体中包含A 1 N 2腺苷受体拮抗剂的药学上可接受的盐的药物组合物。 本发明的组合物可用于治疗和预防呼吸系统疾病的方法。
Abstract:
Triazole derivatives and pharmaceutical compositions containing the derivatives are disclosed as being useful in inhibiting the activity of the receptor protein tyrosine kinase Axl. Methods of using the derivatives in treating diseases or conditions associated with Axl catalytic activity are also disclosed.
Abstract:
The present invention provides compounds that are effective in treating central nervous system disorders and maintaining normal brain function. Methods of making and using the compounds are also provided.
Abstract:
The present invention relates to pyridyl substituted heterocycles and hydro isomers thereof and pharmaceutical compositions thereof that inhibit replication and/or proliferation of HCV virus. The present invention also relates to the use of the pyridyl heterocycles and hydro isomers thereof and/or pharmaceutical compositions comprising the compounds to treat or prevent HCV infections.
Abstract:
Compounds of the general formula (I) are described: wherein A is a 5- or 6-membered aromatic or heteroaromatic ring. Compositions comprising such compounds and methods of use thereof are also described.